Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 9/20 | 0.68 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | MTOR | P42345 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4601843 | 1.00 | GPR84 (0.68) | GPR84FFAR1FFAR4SPHK1PPARD | |
| SCHEMBL3955262 | 1.00 | GPR84 (0.68) | GPR84FFAR1FFAR4SPHK1PPARD | |
| SCHEMBL14885535 | 0.91 | GPR84 (0.55) | GPR84FFAR1FFAR4ALDH1A1TSHR | |
| SCHEMBL28284749 | 0.84 | GPR84 (0.63) | GPR84FFAR1FFAR4SPHK1PPARD | |
| SCHEMBL19611417 | 0.84 | GPR84 (0.63) | GPR84FFAR1FFAR4SPHK1PPARD | |
| SCHEMBL1483983 | 0.84 | GPR84 (0.63) | GPR84FFAR1FFAR4SPHK1PPARD | |
| SCHEMBL4957082 | 0.84 | GPR84 (0.63) | GPR84FFAR1FFAR4SPHK1PPARD | |
| SCHEMBL8633366 | 0.83 | FFAR4 (0.78) | GPR84FFAR1FFAR4PPARDMAPT | |
| SCHEMBL1274520 | 0.83 | FFAR4 (0.78) | GPR84FFAR1FFAR4PPARDMAPT | |
| SCHEMBL4402579 | 0.83 | FFAR4 (0.78) | GPR84FFAR1FFAR4PPARDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7556960-B2 | Pseudomycin production by pseudomonas syringae | ELI LILLY AND COMPANY (US) | 2009-07-07 | — | — | US | disclosed |
| EP-1173471-B1 | PSEUDOMYCIN ANALOGS | LILLY CO ELI (US) | 2008-04-30 | — | — | EP | disclosed |
| US-20080090731-A1 | PSEUDOMYCINS USEFUL AGAINST PLANT DISEASES | MONTANA STATE UNIVERSITY | 2008-04-17 | — | — | US | disclosed |
| US-7326689-B2 | Pseudomycins useful against plant diseases | ELI LILLY AND COMPANY (US) | 2008-02-05 | — | — | US | disclosed |
| WO-2007095259-A2 | ANTIMYCOTIC RHAMNOLIPID COMPOSITIONS AND RELATED METHODS OF USE | JENEIL BIOTECH, INC. (US) | 2007-08-23 | — | — | WO | disclosed |
| US-20070191292-A1 | Antimycotic rhamnolipid compositions and related methods of use | JENEIL BIOTECH, INC. | 2007-08-16 | — | — | US | disclosed |
| EP-1171576-B1 | PSEUDOMYCIN PRODUCTION BY PSEUDOMONAS SYRINGAE | LILLY CO ELI (US) | 2007-07-11 | — | — | EP | disclosed |
| US-20060257973-A1 | Pseudomycin production by pseudomonas syringae | ELI LILLY AND COMPANY | 2006-11-16 | — | — | US | disclosed |
| US-6919188-B1 | Pseudomycin production by Pseudomonas syringae | ELI LILLY AND COMPANY (US) | 2005-07-19 | — | — | US | disclosed |
| EP-1326494-B1 | PSEUDOMYCINS USEFUL AGAINST PLANT DISEASES | UNIV MONTANA RES DEV INST (US) | 2005-05-18 | — | — | EP | disclosed |
| US-20030008814-A1 | Pseudomycin phosphate prodrugs | ELI LILLY AND COMPANY | 2003-01-09 | — | — | US | disclosed |
| CN-1360505-A | Pseudomycin antifungal compositions and methods of their use | LILLY CO ELI (US) | 2002-07-24 | — | — | CN | disclosed |
| CN-1355812-A | Pseudomycin analogs | LILLY CO ELI (US) | 2002-06-26 | — | — | CN | disclosed |
| WO-2002015696-A2 | PSEUDOMYCINS USEFUL AGAINST PLANT DISEASES | RESEARCH AND DEVELOPMENT INSTITUTE, INC. (US) | 2002-02-28 | — | — | WO | disclosed |
| EP-1173471-A2 | PSEUDOMYCIN ANALOGS | ELI LILLY AND COMPANY (US) | 2002-01-23 | — | — | EP | disclosed |
| EP-1171150-A2 | PSEUDOMYCIN ANTIFUNGAL COMPOSITIONS AND METHODS FOR THEIR USE | ELI LILLY AND COMPANY (US) | 2002-01-16 | — | — | EP | disclosed |
| EP-1171576-A1 | PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE) | ELI LILLY AND COMPANY (US) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000062793-A2 | PSEUDOMYCIN ANTIFUNGAL COMPOSITIONS AND METHODS FOR THEIR USE | ELI LILLY AND COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000063345-A1 | PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE) | ELI LILLY AND COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000063237-A2 | PSEUDOMYCIN ANALOGS | ELI LILLY AND COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008814-A1 | Pseudomycin phosphate prodrugs | PMM2, ME1, BPGM | GPR84 2705/4885FFAR1 2857/4885FFAR4 3071/4885 |
| US-20060257973-A1 | Pseudomycin production by pseudomonas syringae | MRPL21, MGAM, MRPS18A | GPR84 3854/4885FFAR1 3715/4885FFAR4 4156/4885 |
| US-20080090731-A1 | PSEUDOMYCINS USEFUL AGAINST PLANT DISEASES | MGAM, PMM2, MANBA | GPR84 4485/4885FFAR1 4721/4885FFAR4 4723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.